EXPLORING CHEMICAL SPACE FOR DRUG DISCOVERY Daniel Svozil Laboratory of Informatics and Chemistry.

Slides:



Advertisements
Similar presentations
1 Real World Chemistry Virtual discovery for the real world Joe Mernagh 19 May 2005.
Advertisements

Analysis of High-Throughput Screening Data C371 Fall 2004.
Christopher Reynolds Supervisor: Prof. Michael Sternberg Bioinformatics Department Division of Molecular Biosciences Imperial College London.
Miroslav Brumovský28th July 2011 Miroslav Brumovský 28 th July 2011 Methods using polarization for in silico fragment-based drug design.
Automated Design of ligands with targeted polypharmacology Jérémy Besnard PhD University of Dundee ELRIG Drug Discovery '13 Manchester 3rd September 2013.
Everardo Macias, Patrick Tomboc Eamonn F. Healy, Chemistry Department,
Medicinal chemistry Chapter 13 New Methods and Techniques.
3D Molecular Structures C371 Fall Morgan Algorithm (Leach & Gillet, p. 8)
Faculté de Chimie, ULP, Strasbourg, FRANCE
In silico small molecule discovery Sales Target gene Discover hit Hit to lead Optimise lead Clinical Target gene identified with a viable assay High throughput.
DRUGGABLE GENOME AND PROTEOME Karen A. Méndez L “the most fruitful basis for the discovery of a new drug is to start with an old drug” (James W Black,
Chemical Biology 1 – Pharmacology Methods for studying protein function – Loss of Function 1. Gene knockouts 2. Conditional knockouts 3. RNAi.
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Privileged Substructures Revisited: Target Community-Selective Scaffolds Jürgen Bajorath Life Science Informatics University of Bonn.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
M. Wagener 3D Database Searching and Scaffold Hopping Markus Wagener NV Organon.
Design of Small Molecule Drugs Targeted to RNA RNA Ontology Group May
2DS01 Statistics 2 for Chemical Engineering lecture 5.
Chemoinformatics in Drug Design
Protein Structure and Drug Discovery Workshop To be held at Monash University, Mebourne, Australia October 3 rd to 4 th 2006 Molecular Visualization Learn.
Important Points in Drug Design based on Bioinformatics Tools History of Drug/Vaccine development –Plants or Natural Product Plant and Natural products.
Predicting Highly Connected Proteins in PIN using QSAR Art Cherkasov Apr 14, 2011 UBC / VGH THE UNIVERSITY OF BRITISH COLUMBIA.
GGAGATTCTGGGCCACTTTGGTTCCCCATGAGCCAAGACGGCACTTCTAATTTGCATTCCCTACCGGAGTCCCTGTCTGTAGCCAGCCTGGCTTTCAGCTGGTGCCCAAAGTGACAAATGTATCTGCAATGACAAAGGTAC CCTGGAAGGGCTCGCCCTCTGCGGAATTTCAGTTCATGCAGGCCTTGGTGCTTCCACATCTGTCCAAGGGCCTTTCAAATGTGACTTTTAACTCTGTGGATTGATTTGCCCGG
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Cédric Notredame (30/08/2015) Chemoinformatics And Bioinformatics Cédric Notredame Molecular Biology Bioinformatics Chemoinformatics Chemistry.
Combinatorial Chemistry and Library Design
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
Christopher Reynolds, Stephen Muggleton and Michael Sternberg Bioinformatics and Computing Departments Imperial College London.
Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
Genomics Research Institute University of Cincinnati Compound Library Wm. L. Seibel January 10, 2007.
Genome Research Institute University of Cincinnati.
Faculté de Chimie, ULP, Strasbourg, FRANCE
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Virtual Screening at the post-genomic era Dr. Didier ROGNAN Bioinformatic Group UMR CNRS 7081 Illkirch, France.
Développement "IN SILICO" de nouveaux extractants et complexants de métaux Alexandre Varnek Laboratoire d’Infochimie, Université Louis Pasteur, Strasbourg,
Drug Discovery Process Massimiliano Beltramo, PhD.
Développement "IN SILICO" de nouveaux extractants et complexants de métaux Alexandre Varnek Laboratoire d’Infochimie, Université Louis Pasteur, Strasbourg,
20/03/2008 Dept. of Pharmaceutics 1. Use of BIOINFORMATICS in Pharmaciutics 2  Presented By  Shafnan Nazar  Hamid Nasir 
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
Page 1 SCAI Dr. Marc Zimmermann Department of Bioinformatics Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Grid-enabled drug discovery.
Università degli Studi di Milano Dipartimento di Scienze Farmaceutiche “Pietro Pratesi” Alessandro Pedretti GriDock: An MPI-based software for virtual.
Ligand-based drug discovery No a priori knowledge of the receptor What information can we get from a few active compounds.
Structural Browsing Indices, Spotfire and Drug Discovery Mark Johnson 1 and Yong-jin Xu 2 1 Pannanugget Consulting; 2 Pharmacia, Inc. Spotfire Users Conference.
Combinatorial Chemistry. Synthesis of many structures (diversity) combinatorial technology, combinatorial library molecular diversity What is Combinatorial.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Mike Gilson Research Interests Computer-aided drug design (CADD) Physical chemistry of molecular recognition Model systems to drive improvement of CADD.
Selecting Diverse Sets of Compounds C371 Fall 2004.
Computer-aided drug discovery (CADD)/design methods have played a major role in the development of therapeutically important small molecules for several.
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
Design of a Compound Screening Collection Gavin Harper Cheminformatics, Stevenage.
Développement "IN SILICO" de nouveaux extractants et complexants de métaux Alexandre Varnek Laboratoire d’Infochimie, Université Louis Pasteur, Strasbourg,
Identification of structurally diverse Growth Hormone Secretagogue (GHS) agonists by virtual screening and structure-activity relationship analysis of.
Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.
Milanesi Luciano Catania, Italy 13/03/2007 Bioinformatics challenges in European projects in Grid. Milanesi Luciano National Research Council Institute.
TCOF 3 :Repositioning of Chemical compounds From Different Classes as part of Virtual Screening Under the Guidance of PI: Dr UCA JALEEL (IISc Research.
Molecular Modeling in Drug Discovery: an Overview
Natural products from plants
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Christopher Reynolds Supervisor: Prof. Michael J.E. Sternberg
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Important Points in Drug Design based on Bioinformatics Tools
CZ3253: Computer Aided Drug design Introduction about the module Prof
Structural Bioinformatics in Drug Discovery
Virtual Screening.
“Structure Based Drug Design for Antidiabetics”
Combinatorial chemistry
Important Points in Drug Design based on Bioinformatics Tools
Megon Walker Bioinformatics Program Boston University
Consortium: National networks in 16 European countries.
Consortium: National networks in 16 European countries.
Presentation transcript:

EXPLORING CHEMICAL SPACE FOR DRUG DISCOVERY Daniel Svozil Laboratory of Informatics and Chemistry University of Chemistry and Technology Prague

What is chemical space? size: 3 × stars, atoms Dokkum & Conroy, Nature, 2010, 468, 940–942 molecule-could-point-to-alien-life/

Size of chemical space mono- to 14-substitute n-hexanes … Weininger, In Encyclopedia of Computational Chemistry, 1998, Vol. 1, estimates vary wildly, commonly given … (MW<500, stable, not all synthetically available) Bohacek et al., Med. Res. Rev., 1996, 16, 3-50 CAS … 1.0 × 10 8 ZINC … 2.3 × 10 7 DrugBank … drugs all numbers as of

Why we need to explore chemical space Lipinski & Hopkins, Nature. 2004, 432, chemical space gene family administered drugs

Methods of its exploration experimental synthesis – combinatorial chemistry related biological data – high-throughput screening (HTS) computational

Computational exploration of chemical space This is basically de novo design. It means that new chemotypes with desired effects are proposed. Two major approaches 1. Exhaustive enumeration 2. Molecular evolution Once you have a virtual library generated, you can apply any of possible virtual screening methods to prioritize your compounds.

Exhaustive enumeration

Molecular evolution systematicaly explore chemical space by clever generation of new compounds Kawai et al., J. Chem. Inf. Model. 2014, 54,

Virtual screening ‘funnel’ ~10 6 – 10 9 molecules VIRTUAL SCREENING INACTIVES HITS GENERATED DATABASE (Q)SAR Docking Pharmacophore models ~10 1 – 10 3 molecules From the presentation by A. Varnek, University of Strasbourg Filters

Molpher Molecular morphing Svozil et al., J. Cheminform., 2014, 6, 7.

Morphing between two molecules Svozil et al., J. Cheminform., 2014, 6, 7.

Morphing operators Svozil et al., J. Cheminform., 2014, 6, 7.

Molpher – what is it good for? Idea: start and target molecules are active against the same target In a systematic way, generate chemical subspace between a start/target pair Explore this subspace for molecules with high potency

IMG library ChEMBL GR ligands Data cleaning and consolidation Molpher Pool of posible ligands ZINC Purchase compounds Experimenta l verification 297 GR ligands paths ~ morphs

ACKNOWLEDGMENT LICH group: Ctibor Škuta, Milan Voršilák, Ivan Čmelo, Martin Šícho, Jiří Novotný IMG group of chemical biology: Petr Bartůněk, David Sedlák and others